Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic use

By sjmartinez • April 6, 2025

Karpouzas GA, Gonzalez-Gay MA, Corrales A, Myasoedova E, Rantapää-Dahlqvist S, Sfikakis PP, Dessein P, Hitchon C, Pascual-Ramos V, Contreras-Yáñez I, Colunga-Pedraza IJ, Galarza-Delgado DA, Azpiri-Lopez JR, Semb AG, van Riel PLCM, Misra DP, Patrick D, Bridal Logstrup B, Hauge EM, Kitas G, Ormseth SR; for An inTernationAl Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA). Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic use. RMD Open. 2025 Apr 5;11(2):e005464. doi: 10.1136/rmdopen-2025-005464. PMID: 40187772.

Tags: Anti-Citrullinated Protein Antibodies, Arthritis, biological therapy, cardiovascular diseases, Harbor UCLA, Publications, Rheumatoid, Rheumatology

Association of Ramus intermedius with increased atherosclerotic plaque in the left main stem

Pourafkari L, Ansari S, Kinninger A, Budoff MJ. Association of Ramus intermedius with increased atherosclerotic plaque in the left main stem. Int J Cardiovasc Imaging.[...]

Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and Design

Plutzky J, Taub PR, Bhatt DL, Al Dhaybi O, Aroda VR, Basile JN, Bloch MJ, Budoff M, Busch RS, Buse JB, Cheung D, Christofides EA,[...]

Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation

Oshima A, Serruys PW, Garg S, McEvoy JW, Wood DA, Doenst T, Taggart DP, Puskas JD, Shajahan A, Sharif F, Miyashita K, Tobe A, Tsai[...]